Two Sigma Investments, LP Regenxbio Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 89,984 shares of RGNX stock, worth $956,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,984
Previous 115,071 21.8%
Holding current value
$956,529
Previous $2.07 Million 8.23%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$12.17 - $24.61 $305,308 - $617,391
-25,087 Reduced 21.8%
89,984 $1.9 Million
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $1.09 Million - $1.77 Million
84,859 Added 280.88%
115,071 $2.07 Million
Q3 2023

Nov 14, 2023
BUY
$16.46 - $19.99 $497,289 - $603,937
30,212 New
30,212 $497,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $877,378 - $1.38 Million
39,362 New
39,362 $1.04 Million
Q2 2022

Aug 15, 2022
SELL
$19.35 - $35.04 $224,460 - $406,464
-11,600 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$24.62 - $34.31 $285,592 - $397,996
11,600 New
11,600 $385,000
Q4 2021

Feb 14, 2022
SELL
$30.19 - $40.28 $4.56 Million - $6.08 Million
-150,994 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $3.85 Million - $6.05 Million
132,394 Added 711.8%
150,994 $6.33 Million
Q2 2021

Aug 16, 2021
SELL
$32.46 - $40.48 $3.25 Million - $4.05 Million
-100,006 Reduced 84.32%
18,600 $723,000
Q1 2021

May 17, 2021
BUY
$33.61 - $49.95 $3.71 Million - $5.52 Million
110,506 Added 1364.27%
118,606 $4.05 Million
Q4 2020

Feb 16, 2021
SELL
$26.52 - $49.35 $22,276 - $41,454
-840 Reduced 9.4%
8,100 $367,000
Q3 2020

Nov 16, 2020
SELL
$27.01 - $40.26 $938,624 - $1.4 Million
-34,751 Reduced 79.54%
8,940 $246,000
Q2 2020

Aug 14, 2020
BUY
$27.75 - $43.44 $1.21 Million - $1.9 Million
43,691 New
43,691 $1.61 Million
Q2 2019

Aug 14, 2019
SELL
$42.0 - $59.29 $1.32 Million - $1.87 Million
-31,473 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$40.82 - $62.45 $3.67 Million - $5.62 Million
-89,947 Reduced 74.08%
31,473 $1.8 Million
Q4 2018

Feb 14, 2019
SELL
$39.11 - $75.15 $277,446 - $533,114
-7,094 Reduced 5.52%
121,420 $5.09 Million
Q3 2018

Nov 14, 2018
BUY
$65.0 - $82.15 $8.35 Million - $10.6 Million
128,514 New
128,514 $9.7 Million
Q2 2018

Aug 14, 2018
SELL
$27.2 - $74.35 $1.68 Million - $4.58 Million
-61,637 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$24.05 - $37.5 $1.6 Million - $2.49 Million
-66,330 Reduced 51.83%
61,637 $1.84 Million
Q4 2017

Feb 14, 2018
BUY
$26.0 - $34.6 $1.74 Million - $2.31 Million
66,775 Added 109.12%
127,967 $4.26 Million
Q3 2017

Nov 14, 2017
BUY
$18.0 - $32.95 $1.1 Million - $2.02 Million
61,192
61,192 $2.02 Million

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
42.1M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $460M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email